GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan · Delayed Price · Currency is PKR 325.66
-15.26 (-4.48%)
At close: Mar 6, 2026
GlaxoSmithKline Pakistan Market Cap
GlaxoSmithKline Pakistan has a market cap or net worth of 103.71 billion as of March 6, 2026. Its market cap has decreased by -20.20% in one year.
Market Cap
103.71B
Enterprise Value
97.07B
Revenue
62.07B
Ranking
n/a
PE Ratio
11.29
Stock Price
325.66
Market Cap Chart
Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 103.71B, an increase of 2,650.37%. That is a compound annual growth rate of 11.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 103.71B | -16.45% |
| Dec 31, 2025 | 124.13B | -1.80% |
| Dec 31, 2024 | 126.40B | 378.26% |
| Dec 29, 2023 | 26.43B | -5.45% |
| Dec 30, 2022 | 27.95B | -35.70% |
| Dec 31, 2021 | 43.47B | -28.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott Laboratories (Pakistan) | 95.94B |
| AGP Limited | 53.56B |
| The Searle Company | 50.92B |
| Highnoon Laboratories | 47.03B |
| Citi Pharma | 17.59B |
| Ferozsons Laboratories | 14.72B |
| Macter International | 13.66B |
| Otsuka Pakistan | 4.43B |